Suchergebnisse - "Durand, Arthur"

PubPharm (44)

1

Subcutaneous Administration of a Zwitterionic Chitosan-Based Hydrogel for Controlled Spatiotemporal Release of Monoclonal Antibodies

enthalten in: Advanced materials (Deerfield Beach, Fla.) | 2024

von Gréa, T. | Jacquot, G. | Durand, A. | +27

2

MEDICAL USE OF FUNCTIONALIZED POLYMER

enthalten in: Europäisches Patentamt | 2024

von MOREL DAPHNÉ | DEUTSCH ERIC | TILLEMENT OLIVIER | +6

3

MEDICAL USE OF FUNCTIONALIZED POLYMER

enthalten in: Europäisches Patentamt | 2024

von MOREL DAPHNÉ | DEUTSCH ERIC | TILLEMENT OLIVIER | +6

4

Enhancing radioprotection : A chitosan-based chelating polymer is a versatile radioprotective agent for prophylactic and therapeutic interventions against radionuclide contamination

enthalten in: PloS one | 2024

von Durand, A. | Borisova, T. | Lux, F. | +11

5

Subcutaneous Administration of a Zwitterionic Chitosan‐Based Hydrogel for Controlled Spatiotemporal Release of Monoclonal Antibodies

enthalten in: Advanced Materials | 2024

von Gréa, T. | Jacquot, G. | Durand, A. | +27

6

Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial

enthalten in: Annals of intensive care | 2023

von Chevret, S. | Bouadma, L. | Dupuis, C. | +103

ErratumIn: Ann Intensive Care. 2023 Sep 29;13(1):95. - PMID 37773550

7

RESPIRATION-RELATED VARIATIONS IN CENTRAL VENOUS PRESSURE AS PREDICTORS OF FLUID RESPONSIVENESS IN SPONTANEOUSLY BREATHING PATIENTS

enthalten in: Shock (Augusta, Ga.) | 2023

von Bourel, C. | Durand, A. | Ter Schiphorst, B. | +7

8

Sepsis-like Energy Deficit Is Not Sufficient to Induce Early Muscle Fiber Atrophy and Mitochondrial Dysfunction in a Murine Sepsis Model

enthalten in: Biology | 2023

von Pierre, A. | Bourel, C. | Favory, R. | +15

9

Assessment of plasma endocan for the prediction of mortality in COVID-19 patients undergoing veno-venous ECMO : A pilot study

enthalten in: Medicina intensiva | 2023

von Levy, C. | Dognon, N. | Normandin, S. | +37

10

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct) : a randomised, double-blind, placebo-controlled phase 3 trial

enthalten in: Critical care (London, England) | 2023

von Trøseid, M. | Arribas, J. | Assoumou, L. | +154

1
2
3
4
5
Nächster »
[5]